Under-the-Tongue Allergy Therapy Cost-Effective
The report also added that SLIT improved symptoms of 63 percent of patients and prevented asthma in 52 percent of patients, compared with 23 percent and 29 percent, respectively, of patients receiving standard treatment.
However, SLIT is not officially in use in the United States as clinical studies endorsed by the FDA are still currently ongoing to get the approval.
0 Comments:
Post a Comment
<< Home